Avg closing price
Price range

15 Ken Griffin Onconova Therapeutics Trades

Ken Griffin's position in Onconova Therapeutics is currently worth $32.5 Thousand. That's 0.00% of their equity portfolio (5066th largest holding). The first Onconova Therapeutics trade was made in Q4 2018. Since then Ken Griffin bought shares six more times and sold shares on eight occasions. The investor's estimated purchase price is $57.7 Thousand, resulting in a loss of 44%.

Avg closing price
Price range
Sold 28.2% shares (-16.8 Thousand shares) Q3 2022
Avg closing price $1.21
Price range $0.88 - $1.45
New holding (+59.5 Thousand shares) Q2 2022
Avg closing price $1.35
Price range $1.04 - $1.90
Sold -40.6 Thousand shares Q1 2022
Avg closing price $1.85
Price range $1.46 - $2.82
Sold 42.5% shares (-30 Thousand shares) Q4 2021
Avg closing price $3.22
Price range $2.49 - $3.73
New holding (+70.6 Thousand shares) Q3 2021
Avg closing price $5.15
Price range $3.81 - $6.76
Sold -3.87 Thousand shares Q2 2021
Avg closing price $9.05
Price range $6.28 - $16.20
Sold 79.9% shares (-15.3 Thousand shares) Q1 2021
Avg closing price $15.09
Price range $7.52 - $26.40
New holding (+19.2 Thousand shares) Q3 2020
Avg closing price $9.96
Price range $3.11 - $20.85
Sold -12.1 Thousand shares Q2 2020
Avg closing price $6.11
Price range $4.17 - $9.21
Increased shares by 212.2% (+8.2 Thousand shares) Q1 2020
Avg closing price $6.28
Price range $4.35 - $9.00
New holding (+3.87 Thousand shares) Q4 2019
Avg closing price $7.47
Price range $1.78 - $16.65
Sold -1.11 Thousand shares Q3 2019
Avg closing price $34.42
Price range $12.74 - $44.70
New holding (+1.11 Thousand shares) Q2 2019
Avg closing price $55.08
Price range $42.75 - $64.50
Sold -925 shares Q1 2019
Avg closing price $47.52
Price range $28.95 - $67.50
New holding (+925 shares) Q4 2018
Avg closing price $68.17
Price range $25.65 - $103.65

Embed chart

Easily embed the chart on your blog or website – it will always update automatically!